LCM
CRL icon

Lakewood Capital Management’s Charles River Laboratories CRL Stock Holding History

Lakewood Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4M Buy
134,000
+65,000
+94% +$11.6M 1.57% 25
2026
Q1 		$11.9M Sell
69,000
-71,240
-51% -$13.2M 0.75% 40
2025
Q4 		$28M Hold
140,240
– – 1.85% 23
2025
Q3 		$21.9M Hold
140,240
– – 1.66% 23
2025
Q2 		$21.3M Hold
140,240
– – 1.59% 23
2025
Q1 		$21.1M Buy
140,240
+28,500
+26% +$4.78M 1.84% 20
2024
Q4 		$20.6M Hold
111,740
– – 1.85% 21
2024
Q3 		$22M Hold
111,740
– – 1.73% 22
2024
Q2 		$23.1M Sell
111,740
-1,000
-0.9% -$227K 1.89% 19
2024
Q1 		$30.5M Sell
112,740
-5,000
-4% -$1.19M 2.49% 16
2023
Q4 		$27.8M Buy
117,740
+30,000
+34% +$5.9M 2.33% 17
2023
Q3 		$17.2M Hold
87,740
– – 1.56% 22
2023
Q2 		$18.4M Hold
87,740
– – 1.6% 21
2023
Q1 		$17.7M Hold
87,740
– – 1.45% 23
2022
Q4 		$19.1M Sell
87,740
-18,000
-17% -$3.93M 1.7% 21
2022
Q3 		$20.8M Sell
105,740
-39,000
-27% -$8.42M 1.75% 20
2022
Q2 		$31M Buy
144,740
+67,640
+88% +$16.5M 1.92% 24
2022
Q1 		$21.9M Buy
+77,100
New +$23.8M 1.1% 31
2021
Q3 		– Sell
-124,000
Closed -$45.9M – 58
2021
Q2 		$45.9M Sell
124,000
-39,000
-24% -$13M 1.89% 22
2021
Q1 		$47.2M Sell
163,000
-14,000
-8% -$3.89M 2% 20
2020
Q4 		$44.2M Sell
177,000
-21,000
-11% -$5M 2.07% 20
2020
Q3 		$44.8M Sell
198,000
-27,000
-12% -$5.6M 2.16% 18
2020
Q2 		$39.2M Buy
+225,000
New +$35.9M 1.69% 22

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Lakewood Capital Management's CRL Position: Q2 2026 in Review

Lakewood Capital Management increased its Charles River Laboratories (CRL) stake by 94% in Q2 2026, buying an estimated $11.6M and bringing the position to 134,000 shares worth $30.4M. The position accounts for 1.57% of the portfolio, ranked #25.

Lakewood Capital Management first reported a position in CRL in Q2 2020 and has held it in 23 quarters since. The position peaked at $47.2M in Q1 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Lakewood Capital Management held 134,000 shares of Charles River Laboratories worth $30.4M as of Q2 2026.
  • Lakewood Capital Management bought 65,000 Charles River Laboratories shares in Q2 2026, an estimated $11.6M.
  • Charles River Laboratories made up 1.57% of Lakewood Capital Management's portfolio in Q2 2026, its #25 holding.
  • Lakewood Capital Management first reported a position in Charles River Laboratories in Q2 2020 and has held it in 23 quarters since.
  • Lakewood Capital Management's Charles River Laboratories position peaked at $47.2M in Q1 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Lakewood Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.